Fig. 5

Diagnostic value of serum HBV RNA in patients with low-level viremia. (A) Receiver operating characteristic curves for biomarkers at week 48 predicting virological response at week 120 in patients with low-level viraemia. (B) Distribution of virological responses at week 120 to the initial and modified treatment regimens according to the cut-off value of the HBV RNA level at week 48